Oncoinvent has published Phase 1 dosimetry data for Radspherin in [...]

The European Commission has approved Erbitux (cetuximab) in combination with [...]

The US FDA has granted Fast Track Designation to SOTIO [...]

A Phase 1/1b clinical trial has begun in Australia to [...]

CuraCell TX has reported new findings supporting its personalised tumour-infiltrating [...]

Pierre Fabre Laboratories has received a positive opinion from the [...]

Primerdesign and Origin Sciences partner to develop a DNA extraction [...]

Promatix Biosciences has reported preclinical data showing its cis-bispecific ADC [...]

Bicara Therapeutics has selected 1500 mg of ficerafusp alfa as [...]

MediciNova has completed patient enrollment in a Phase 2 clinical [...]